MARKET

DHR

DHR

Danaher
NYSE

Real-time Quotes | Nasdaq Last Sale

324.53
+0.53
+0.16%
After Hours: 321.00 -3.53 -1.09% 19:16 09/17 EDT
OPEN
324.84
PREV CLOSE
324.00
HIGH
329.18
LOW
321.82
VOLUME
3.46M
TURNOVER
--
52 WEEK HIGH
333.96
52 WEEK LOW
201.44
MARKET CAP
231.68B
P/E (TTM)
43.95
1D
5D
1M
3M
1Y
5Y
Bny Mellon Variable Investment Fund Buys Visa Inc, Devon Energy Corp, Aramark, Sells Chubb, ...
GuruFocus News · 1d ago
BlackRock Variable Series Funds, Inc. Buys Sea, Etsy Inc, Danaher Corp, Sells Boston Scientific ...
GuruFocus News · 1d ago
Raven (RAVN) Shareholders Approve Deal With CNH Industrial
Zacks.com · 2d ago
Carlisle (CSL) Prices Notes Offering, To Use Funds to Lower Debt
Zacks.com · 2d ago
Here's Why You Should Consider Investing in Crane (CR) Now
Zacks.com · 2d ago
Forget Earnings Growth, Focus on Beat With These 5 Stocks
Zacks.com · 2d ago
Predisposition Biomarkers Market- Expected Growth and its Factors, CAGR, Industry Size, Business Prospects and Forecast 2030
Research Nester published a report titled which delivers detailed overview of the global predisposition biomarkers market in terms of market segmentation by type, application, end-user, and by region.
AmericaNewsHour · 2d ago
Great-West Large Cap Value Fund Buys Anthem Inc, Southern Co, Sempra Energy, Sells Cisco ...
GuruFocus News · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DHR. Analyze the recent business situations of Danaher through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DHR stock price target is 334.69 with a high estimate of 370.00 and a low estimate of 272.00.
EPS
Institutional Holdings
Institutions: 2.22K
Institutional Holdings: 605.55M
% Owned: 84.82%
Shares Outstanding: 713.90M
TypeInstitutionsShares
Increased
658
17.88M
New
146
5.56M
Decreased
677
17.41M
Sold Out
92
1.21M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.54%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/Director
Steven Rales
President/Chief Executive Officer/Director
Rainer Blair
Co-Founder/Director
Mitchell Rales
Chief Financial Officer/Executive Vice President
Matthew McGrew
Executive Vice President
Jennifer Honeycutt
Executive Vice President
Joakim Weidemanis
Senior Vice President/Chief Accounting Officer
Robert Lutz
Senior Vice President/Chief Scientific Officer
Jose-Carlos Gutierrez-Ramos
Senior Vice President/General Counsel
Brian Ellis
Senior Vice President/Director of Human Resources
Angela Lalor
Senior Vice President
William King
Senior Vice President
Daniel Raskas
Lead Director/Independent Director
Linda Hefner Filler
Director
A. Shane Sanders
Independent Director
Teri List-Stoll
Independent Director
Walter Lohr
Independent Director
Jessica Mega
Independent Director
Pardis Sabeti
Independent Director
John Schwieters
Independent Director
Alan Spoon
Independent Director
Raymond Stevens
Independent Director
Elias Zerhouni
Declaration Date
Dividend Per Share
Ex-Div Date
09/14/2021
Dividend USD 0.21
09/29/2021
05/05/2021
Dividend USD 0.21
06/24/2021
02/23/2021
Dividend USD 0.21
03/25/2021
12/08/2020
Dividend USD 0.18
12/24/2020
09/15/2020
Dividend USD 0.18
09/25/2020
05/05/2020
Dividend USD 0.18
06/25/2020
02/20/2020
Dividend USD 0.18
03/26/2020
12/10/2019
Dividend USD 0.17
12/26/2019
09/10/2019
Dividend USD 0.17
09/26/2019
05/07/2019
Dividend USD 0.17
06/27/2019
03/08/2019
Dividend USD 0.17
03/28/2019
12/03/2018
Dividend USD 0.16
12/27/2018
09/11/2018
Dividend USD 0.16
09/27/2018
05/08/2018
Dividend USD 0.16
06/28/2018
02/20/2018
Dividend USD 0.16
03/28/2018
12/05/2017
Dividend USD 0.14
12/28/2017
09/12/2017
Dividend USD 0.14
09/28/2017
05/10/2017
Dividend USD 0.14
06/28/2017
02/22/2017
Dividend USD 0.14
03/29/2017
12/07/2016
Dividend USD 0.125
12/28/2016
  • All
  • Financials
  • Insiders
More
About DHR
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Webull offers kinds of Danaher Corporation stock information, including NYSE:DHR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DHR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DHR stock methods without spending real money on the virtual paper trading platform.